Vaccine Weekly
Susan Hasty, Publisher
Table of Contents . . . December 17th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Hepatitis C Vaccine - T-cell response against hepatitis C virus optimized
Toxoplasmosis - Complete cross-reactivity found in Toxoplasma gondii isolates
Drug Delivery - Scientists describe biochemistry of vaccine adjuvants
Histoplasmosis - Antibodies to histone-like protein protect against Histoplasma
Malaria Vaccine - Expression of protein of Plasmodium yoelii protects against malaria
Respiratory Syncytial Virus - Immune response to RSV infection linked to nasal antibody responses
Vaccine Development - Therapeutic vaccines against infectious diseases face challenges
AIDS Funding - Five-year, $1.5 million grant to fight spread of HIV/AIDS and TB in Africa
Antimicrobial Resistance - Drug resistance linked to location and emm type of Streptococcus
Breast Cancer - Results of Taxotere in breast cancer trial highlighted at symposium
Cancer Vaccine - Antitumor immunity initiated by antigen collocation in same vaccine
Cancer Vaccine - Immunotherapy of AMLs: Development of vaccines and cell therapy approaches
Cancer Vaccine - Vaccinal cell therapy in melanoma showing promise
Cell Biology - Scientists find marker for long-term immunity
Finance - Drug delivery firm closes private placement, ends 3Q with $5.3M
Finance - Vaccine company reports net loss of $8.2 million in third-quarter results
HIV/AIDS Vaccine - SIV Gag DNA vaccines exhibit enhanced immunogenicity
Hepatitis B Vaccine - Hepatitis B surface antigen purified using a plant-derived antibody
Hepatitis B Vaccine - Hepatitis antibodies persist 10 years in vaccinated healthcare workers
Hepatitis C Vaccine - Exposure to low doses of HCV induces cellular immune responses
Immunology - Gene transfer corrects defective T-cell responses in study models
Infectious Disease - Understanding how lymph nodes respond to infection may redefine immunology
Influenza - U.S. is poorly prepared for influenza pandemic, experts warn
Influenza - Worst flu season in 30 years predicted
Measles - Attenuated measles virus, GM-CSF expression enhances neutrophil antitumor action
Meningococcal Vaccine - Right decisions in public health based on science and expertise
Mergers and Acquisitions - Henry Schein expands product offerings through two strategic acquisitions
Oncology - Injecting tumors with CpG-oligodeoxynucleotide promotes antitumor response
Policy - Records link patients and disease for future policy implementation
Prion Disease - Heparan sulfate appears to act in the reconformation of PrPC into prion PrPSc
Reovirus - Epitope-tagged viral sigma3 proteins incorporated into reovirus virions
SARS - China to test experimental vaccine
Smallpox - Company licenses technology from NIAID for vaccine for smallpox
Targeted Therapy - T-cell adaptor proteins may be useful targets for transplantation, leukemia
Vaccine Development - Vaccine company clarifies proteomics strategy
Vaccine Safety - Vitamin A supplementation linked to vaccine effects in children
West Nile Virus - Professor wins CDC grant to combat emerging infections
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
